Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Case Report

Published on 28 Oct 2024

Response to furmonertinib in a patient with non-small cell lung cancer harboring HER2 exon 21 insertion mutation: a case report

in Cancer Molecular Targets and Therapeutics

Chunxiao Ni
Ling Zhang
Xin Yu
Yu Pang

Frontiers in Oncology

doi 10.3389/fonc.2024.1440379

986 views

Original Research

Published on 24 Oct 2024

Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway

in Cancer Molecular Targets and Therapeutics

Xiao Li
Mengna Cui
Long Xu
Qie Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1483660

1,831 views

Review

Published on 24 Oct 2024

Role of non-coding RNA in exosomes for the diagnosis and treatment of osteosarcoma

in Cancer Molecular Targets and Therapeutics

Xin Liu
Yaling Wang
Chenwen Wang
Xinyuan Wang
Gangqiang Tang
Zhou Xiong
Wei Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1469833

953 views

Original Research

Published on 18 Oct 2024

Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion

in Cancer Molecular Targets and Therapeutics

Lisa A. King
Milon de Jong
Myrthe Veth
David Lutje Hulsik
Parsa Yousefi
Victoria Iglesias-Guimarais
Pauline M. van Helden
Tanja D. de Gruijl
Hans J. van der Vliet

Frontiers in Oncology

doi 10.3389/fonc.2024.1474007

1,570 views

Opinion

Published on 18 Oct 2024

The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcoma

in Cancer Molecular Targets and Therapeutics

Jiro Ichikawa
Tomonori Kawasaki
Kojiro Onohara
Satoshi Kanno
Masanori Wako
Satoshi Ochiai
Kaoru Aoki
Hirotaka Haro

Frontiers in Oncology

doi 10.3389/fonc.2024.1466399

506 views

Correction

Published on 17 Oct 2024

Corrigendum: Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts

in Cancer Molecular Targets and Therapeutics

Yaxin Tian
Yanghongyan Jiang
Ping Ma
Xiaowei Ma
Liang Du
Fengkui Wang
Xiaodong Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1501235

388 views

Original Research

Published on 16 Oct 2024

Antitumor activity of PAbs generated by immunization with a novel HER3-targeting protein-based vaccine candidate in preclinical models

in Cancer Molecular Targets and Therapeutics

Ernesto Bermúdez-Abreut
Gretchen Bergado Báez
Melissa Martínez Pestano
Giuseppe Attanasio
Carlos Yordan Gonzales Castillo
Diana Rosa Hernández Fernández
Rydell Alvarez-Arzola
Andrea Alimonti
Belinda Sánchez-Ramírez

Frontiers in Oncology

doi 10.3389/fonc.2024.1472607

773 views

Review

Published on 15 Oct 2024

PTK7: an underestimated contributor to human cancer

in Cancer Molecular Targets and Therapeutics

Zhipeng Jin
Tianyu Guo
Xue Zhang
Xin Wang
Yefu Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1448695

1,636 views

Original Research

Published on 14 Oct 2024

Antagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapy

in Cancer Molecular Targets and Therapeutics

Beiyuan Liang
Xuanxuan Xing
Hayden Storts
Zhen Ye
Hazel Claybon
Ryan Austin
Rachel Ding
Bei Liu
Haitao Wen
Wayne O. Miles

Frontiers in Oncology

doi 10.3389/fonc.2024.1441935

1,779 views

Original Research

Published on 14 Oct 2024

Integration of ubiquitination-related genes in predictive signatures for prognosis and immunotherapy response in sarcoma

in Cancer Molecular Targets and Therapeutics

Haotian Qin
Tiantian Qi
Juan Xu
Tianbing Wang
Hui Zeng
Jun Yang
Fei Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1446522

1,357 views

Original Research

Published on 11 Oct 2024

Association of mutation profiles with metastasis in patients with non-small cell lung cancer

in Cancer Molecular Targets and Therapeutics

Yingxue Li
Zheng Zheng
Li Wang
Lin Han
Ying Du
Xuedong Zhang
Xia Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1451576

1,113 views

Review

Published on 11 Oct 2024

Lung cancer cell-derived exosomes: progress on pivotal role and its application in diagnostic and therapeutic potential

in Cancer Molecular Targets and Therapeutics

Aimi Syamima Abdul Manap
Faith Malambo Ngwenya
Meilarshny Kalai Selvan
Syarafina Arni
Fathimath Hishma Hassan
Ammar Danish Mohd Rudy
Nurul Nadiah Abdul Razak

Frontiers in Oncology

doi 10.3389/fonc.2024.1459178

2,282 views

Original Research

Published on 11 Oct 2024

Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients

in Cancer Molecular Targets and Therapeutics

Yuya Hirasawa
Yutaro Kubota
Emiko Mura
Risako Suzuki
Toshiaki Tsurui
Nana Iriguchi
Tomoyuki Ishiguro
Ryotaro Ohkuma
Masahiro Shimokawa
Hirotsugu Ariizumi

Frontiers in Oncology

doi 10.3389/fonc.2024.1449941

902 views

Original Research

Published on 07 Oct 2024

RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides

in Cancer Molecular Targets and Therapeutics

Maria Danielsen
Thomas Emmanuel
Morten Muhlig Nielsen
Lise Maria Lindahl
Maria Gluud
Niels Ødum
Line Raaby
Torben Steiniche
Lars Iversen
Rikke Bech

Frontiers in Oncology

doi 10.3389/fonc.2024.1421443

1,031 views

Original Research

Published on 07 Oct 2024

POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma

in Cancer Molecular Targets and Therapeutics

Laura del Puerto-Nevado
María J. Fernández-Aceñero
Arancha Cebrián
Yuliia Fatych
Luis I. Díez-Valladares
Elia Pérez-Aguirre
Sofía de la Serna
Alejandra García-Botella
Javier Martínez-Useros
Jesús García-Foncillas

Frontiers in Oncology

doi 10.3389/fonc.2024.1433179

871 views

Original Research

Published on 03 Oct 2024

Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs

in Cancer Molecular Targets and Therapeutics

Terri V. Cornforth
Nathifa Moyo
Suzanne Cole
Emily P. S. Lam
Tatiana Lobry
Ron Wolchinsky
Angharad Lloyd
Katarzyna Ward
Eleanor M. Denham
Giulia Masi

Frontiers in Oncology

doi 10.3389/fonc.2024.1419528

2,232 views
2 citations

Navigation group

Articles

Response to furmonertinib in a patient with non-small cell lung cancer harboring HER2 exon 21 insertion mutation: a case report

Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway

Role of non-coding RNA in exosomes for the diagnosis and treatment of osteosarcoma

Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion

The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcoma

Corrigendum: Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts

Antitumor activity of PAbs generated by immunization with a novel HER3-targeting protein-based vaccine candidate in preclinical models

PTK7: an underestimated contributor to human cancer

Antagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapy

Integration of ubiquitination-related genes in predictive signatures for prognosis and immunotherapy response in sarcoma

Association of mutation profiles with metastasis in patients with non-small cell lung cancer

Lung cancer cell-derived exosomes: progress on pivotal role and its application in diagnostic and therapeutic potential

Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients

RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides

POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma

Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs